INBS Nasdaq

Intelligent Bio Solutions Inc

INBS | $2.58 -7.19% -7.75% 51K

(0.0% 1d) (-34.6% 1m) (6.9% 1y) (0.0% 2d) (4.5% 3d) (-0.7% 7d) (8.73% volume)
Earnings Calendar: 2024-02-13
Market Cap: $ 7,338,175
https://gbs.inc
Sec Filling | Patents | 8 employees

(US) GBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. With the world-first Biosensor Platform, GBS Inc. is developing and launching diagnostic tests urgently needed to help eradicate COVID-19 and change the lives of people living with diabetes.

diagnostics diabetes diabetic covid

add to watch list Paper trade email alert is off

Press-releases

Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
INBS | $2.58 -7.19% -7.75% 51K

Manufacturing

| 3.73% | O: 4.48% H: 0.0% C: 0.0%
revenue solutions results

Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader
Published: 2024-04-11 (Crawled : 13:00) - globenewswire.com
INBS | $2.58 -7.19% -7.75% 51K

Manufacturing

| -17.75% | O: 4.73% H: 0.0% C: -5.37%
patent solutions for grant

Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC
Published: 2024-03-26 (Crawled : 18:00) - biospace.com/
INBS | $2.58 -7.19% -7.75% 51K

Manufacturing

| -34.59% | O: -3.06% H: 7.74% C: 3.64%
conference solutions

Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Published: 2024-03-12 (Crawled : 00:00) - globenewswire.com
INBS | $2.58 -7.19% -7.75% 51K

Manufacturing

| -40.22% | O: -1.94% H: 4.82% C: 0.66%
nasdaq million solutions

Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Published: 2024-03-11 (Crawled : 12:30) - globenewswire.com
INBS | $2.58 -7.19% -7.75% 51K

Manufacturing

| -39.57% | O: 0.0% H: 9.13% C: -1.3%
nasdaq million solutions

Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024
Published: 2024-03-01 (Crawled : 13:30) - globenewswire.com
INBS | $2.58 -7.19% -7.75% 51K

Manufacturing

| -44.4% | O: 5.0% H: 7.24% C: 5.14%
conference solutions growth

Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway
Published: 2024-02-28 (Crawled : 13:30) - globenewswire.com
INBS | $2.58 -7.19% -7.75% 51K

Manufacturing

| -42.92% | O: 0.82% H: 3.91% C: -2.44%
fda research solutions study

Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity Requirement
Published: 2024-02-16 (Crawled : 13:30) - globenewswire.com
INBS | $2.58 -7.19% -7.75% 51K

Manufacturing

| -42.92% | O: -1.44% H: 1.27% C: -7.92%
nasdaq solutions

Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights
Published: 2024-02-09 (Crawled : 13:30) - globenewswire.com
INBS | $2.58 -7.19% -7.75% 51K

Manufacturing

| -3.47% | O: 12.15% H: 262.23% C: 109.44%
solutions financial results

Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross Proceeds
Published: 2024-02-05 (Crawled : 14:00) - globenewswire.com
INBS | $2.58 -7.19% -7.75% 51K

Manufacturing

| -53.28% | O: -33.28% H: 3.27% C: -8.31%
million solutions

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001493152-24-010846	4	2024-03-21	2024-03-20	Sell	X	9394	0
0001493152-24-010846	4	2024-03-21	2024-03-20	Buy	X	9394	19180